These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 35330412)

  • 1. Multi-Omics Characterization of Early- and Adult-Onset Major Depressive Disorder.
    Grant CW; Barreto EF; Kumar R; Kaddurah-Daouk R; Skime M; Mayes T; Carmody T; Biernacka J; Wang L; Weinshilboum R; Trivedi MH; Bobo WV; Croarkin PE; Athreya AP
    J Pers Med; 2022 Mar; 12(3):. PubMed ID: 35330412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network science approach elucidates integrative genomic-metabolomic signature of antidepressant response and lifetime history of attempted suicide in adults with major depressive disorder.
    Grant CW; Wilton AR; Kaddurah-Daouk R; Skime M; Biernacka J; Mayes T; Carmody T; Wang L; Lazaridis K; Weinshilboum R; Bobo WV; Trivedi MH; Croarkin PE; Athreya AP
    Front Pharmacol; 2022; 13():984383. PubMed ID: 36263124
    [No Abstract]   [Full Text] [Related]  

  • 3. Multi-omics driven predictions of response to acute phase combination antidepressant therapy: a machine learning approach with cross-trial replication.
    Joyce JB; Grant CW; Liu D; MahmoudianDehkordi S; Kaddurah-Daouk R; Skime M; Biernacka J; Frye MA; Mayes T; Carmody T; Croarkin PE; Wang L; Weinshilboum R; Bobo WV; Trivedi MH; Athreya AP
    Transl Psychiatry; 2021 Oct; 11(1):513. PubMed ID: 34620827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective Serotonin Reuptake Inhibitor Pharmaco-Omics: Mechanisms and Prediction.
    Nguyen TTL; Liu D; Ho MF; Athreya AP; Weinshilboum R
    Front Pharmacol; 2020; 11():614048. PubMed ID: 33510640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide Association for Major Depression Through Age at Onset Stratification: Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium.
    Power RA; Tansey KE; Buttenschøn HN; Cohen-Woods S; Bigdeli T; Hall LS; Kutalik Z; Lee SH; Ripke S; Steinberg S; Teumer A; Viktorin A; Wray NR; Arolt V; Baune BT; Boomsma DI; Børglum AD; Byrne EM; Castelao E; Craddock N; Craig IW; Dannlowski U; Deary IJ; Degenhardt F; Forstner AJ; Gordon SD; Grabe HJ; Grove J; Hamilton SP; Hayward C; Heath AC; Hocking LJ; Homuth G; Hottenga JJ; Kloiber S; Krogh J; Landén M; Lang M; Levinson DF; Lichtenstein P; Lucae S; MacIntyre DJ; Madden P; Magnusson PKE; Martin NG; McIntosh AM; Middeldorp CM; Milaneschi Y; Montgomery GW; Mors O; Müller-Myhsok B; Nyholt DR; Oskarsson H; Owen MJ; Padmanabhan S; Penninx BWJH; Pergadia ML; Porteous DJ; Potash JB; Preisig M; Rivera M; Shi J; Shyn SI; Sigurdsson E; Smit JH; Smith BH; Stefansson H; Stefansson K; Strohmaier J; Sullivan PF; Thomson P; Thorgeirsson TE; Van der Auwera S; Weissman MM; ; Breen G; Lewis CM
    Biol Psychiatry; 2017 Feb; 81(4):325-335. PubMed ID: 27519822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics-Driven Prediction of Antidepressant Treatment Outcomes: A Machine-Learning Approach With Multi-trial Replication.
    Athreya AP; Neavin D; Carrillo-Roa T; Skime M; Biernacka J; Frye MA; Rush AJ; Wang L; Binder EB; Iyer RK; Weinshilboum RM; Bobo WV
    Clin Pharmacol Ther; 2019 Oct; 106(4):855-865. PubMed ID: 31012492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: metabolomics-informed genomics.
    Liu D; Ray B; Neavin DR; Zhang J; Athreya AP; Biernacka JM; Bobo WV; Hall-Flavin DK; Skime MK; Zhu H; Jenkins GD; Batzler A; Kalari KR; Boakye-Agyeman F; Matson WR; Bhasin SS; Mushiroda T; Nakamura Y; Kubo M; Iyer RK; Wang L; Frye MA; Kaddurah-Daouk R; Weinshilboum RM
    Transl Psychiatry; 2018 Jan; 8(1):10. PubMed ID: 29317604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Multi-Trait Association Analysis of Brain Disorders and Platelet Traits Identifies Novel Susceptibility Loci for Major Depression, Alzheimer's and Parkinson's Disease.
    Tirozzi A; Quiccione MS; Cerletti C; Donati MB; de Gaetano G; Iacoviello L; Gialluisi A
    Cells; 2023 Jan; 12(2):. PubMed ID: 36672180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the "gene-protein-metabolite" network of coronary heart disease with phlegm and blood stasis syndrome by integrated multi-omics strategy.
    Yang G; Zhou S; He H; Shen Z; Liu Y; Hu J; Wang J
    Front Pharmacol; 2022; 13():1022627. PubMed ID: 36523490
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of the Polygenic Scores for Personality Traits and Response to Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder.
    Amare AT; Schubert KO; Tekola-Ayele F; Hsu YH; Sangkuhl K; Jenkins G; Whaley RM; Barman P; Batzler A; Altman RB; Arolt V; Brockmöller J; Chen CH; Domschke K; Hall-Flavin DK; Hong CJ; Illi A; Ji Y; Kampman O; Kinoshita T; Leinonen E; Liou YJ; Mushiroda T; Nonen S; Skime MK; Wang L; Kato M; Liu YL; Praphanphoj V; Stingl JC; Bobo WV; Tsai SJ; Kubo M; Klein TE; Weinshilboum RM; Biernacka JM; Baune BT
    Front Psychiatry; 2018; 9():65. PubMed ID: 29559929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systems Approach to Identify Common Genes and Pathways Associated with Response to Selective Serotonin Reuptake Inhibitors and Major Depression Risk.
    Srivastava A; Singh P; Gupta H; Kaur H; Kanojia N; Guin D; Sood M; Chadda RK; Yadav J; Vohora D; Saso L; Kukreti R
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31018568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of GWAS and brain eQTL identifies FLOT1 as a risk gene for major depressive disorder.
    Zhong J; Li S; Zeng W; Li X; Gu C; Liu J; Luo XJ
    Neuropsychopharmacology; 2019 Aug; 44(9):1542-1551. PubMed ID: 30771789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Novel ALX4 Gene Polymorphisms with Antidepressant Treatment Response: Findings from the CO-MED Trial.
    Gadad BS; Raj P; Jha MK; Carmody T; Dozmorov I; Mayes TL; Wakeland EK; Trivedi MH
    Mol Neuropsychiatry; 2018 Jun; 4(1):7-19. PubMed ID: 29998114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Pharmacogenomic Testing Improve Clinical Outcomes for Major Depressive Disorder? A Systematic Review of Clinical Trials and Cost-Effectiveness Studies.
    Rosenblat JD; Lee Y; McIntyre RS
    J Clin Psychiatry; 2017 Jun; 78(6):720-729. PubMed ID: 28068459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coordinate-Based Network Mapping of Brain Structure in Major Depressive Disorder in Younger and Older Adults: A Systematic Review and Meta-Analysis.
    Zhukovsky P; Anderson JAE; Coughlan G; Mulsant BH; Cipriani A; Voineskos AN
    Am J Psychiatry; 2021 Dec; 178(12):1119-1128. PubMed ID: 34645274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of SLC25A37 as a major depressive disorder risk gene.
    Huo YX; Huang L; Zhang DF; Yao YG; Fang YR; Zhang C; Luo XJ
    J Psychiatr Res; 2016 Dec; 83():168-175. PubMed ID: 27643475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting the genetic heterogeneity of depression through age at onset.
    Power RA; Keers R; Ng MY; Butler AW; Uher R; Cohen-Woods S; Ising M; Craddock N; Owen MJ; Korszun A; Jones L; Jones I; Gill M; Rice JP; Hauser J; Henigsberg N; Maier W; Zobel A; Mors O; Placentino AS; Rietschel M; Souery D; Kozel D; Preisig M; Lucae S; Binder EB; Aitchison KJ; Tozzi F; Muglia P; Breen G; Craig IW; Farmer AE; Müller-Myhsok B; McGuffin P; Lewis CM
    Am J Med Genet B Neuropsychiatr Genet; 2012 Oct; 159B(7):859-68. PubMed ID: 22915352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A haplotype of glycogen synthase kinase 3β is associated with early onset of unipolar major depression.
    Saus E; Soria V; Escaramís G; Crespo JM; Valero J; Gutiérrez-Zotes A; Martorell L; Vilella E; Menchón JM; Estivill X; Gratacòs M; Urretavizcaya M
    Genes Brain Behav; 2010 Oct; 9(7):799-807. PubMed ID: 20618448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating genome-wide association study and expression quantitative trait loci data identifies NEGR1 as a causal risk gene of major depression disorder.
    Wang X; Cheng W; Zhu J; Yin H; Chang S; Yue W; Yu H
    J Affect Disord; 2020 Mar; 265():679-686. PubMed ID: 32090785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing Developmental Trajectories and the Role of Neuropsychiatric Genetic Risk Variants in Early-Onset Depression.
    Rice F; Riglin L; Thapar AK; Heron J; Anney R; O'Donovan MC; Thapar A
    JAMA Psychiatry; 2019 Mar; 76(3):306-313. PubMed ID: 30326013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.